Off-Label and Unlicenced Medicine Use among Hospitalised Children in South Africa: Practice and Policy Implications.
Hlayiseka MathevulaNatalie SchellackSamuel OrubuBrian B GodmanMoliehi MatlalaPublished in: Pharmacy (Basel, Switzerland) (2023)
The frequency of unlicensed and off-label medicine prescribing shown in this study is consistent with the literature and can be considered high. This practice can pose a risk because it adversely affects patients if not properly regulated. Attention is needed to ensure future high-quality, safe, and effective use of medicines.
Keyphrases
- primary care
- healthcare
- south africa
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- young adults
- public health
- prognostic factors
- peritoneal dialysis
- quality improvement
- transcription factor
- emergency department
- current status
- hepatitis c virus
- human immunodeficiency virus
- patient reported outcomes
- hiv infected
- antiretroviral therapy
- community acquired pneumonia